Photo by nci from unsplash
Thrombocytopenia before and after transcatheter aortic valve replacement (TAVR) is frequently observed, but its clinical impact on later outcomes remains unclear. We retrospectively reviewed a total of 444 consecutive patients… Click to show full abstract
Thrombocytopenia before and after transcatheter aortic valve replacement (TAVR) is frequently observed, but its clinical impact on later outcomes remains unclear. We retrospectively reviewed a total of 444 consecutive patients who underwent TAVR (transfemoral, n = 370; nontransfemoral, n = 74) at
Keywords:
aortic valve;
705 thrombocytopenia;
tct 705;
transcatheter aortic
Journal Title: Journal of the American College of Cardiology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of the American College of Cardiology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!